These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18666472)

  • 41. Electrocardiogram mimics of acute ST-segment elevation myocardial infarction: insights from cardiac magnetic resonance imaging in patients with tako-tsubo (stress) cardiomyopathy.
    Sharkey SW
    J Electrocardiol; 2008; 41(6):621-5. PubMed ID: 18790504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ACC/AHA guideline update for the management of ST-segment elevation myocardial infarction.
    Campbell-Scherer DL; Green LA
    Am Fam Physician; 2009 Jun; 79(12):1080-6. PubMed ID: 19530638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Methods of evaluating proposed treatments in the secondary prevention of myocardial infarction].
    Castaigne A; Duval-Moulin AM; Dubois-Randé JL
    Arch Mal Coeur Vaiss; 1987 Dec; 80 Spec No():95-100. PubMed ID: 3128239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical indications for implant of CID in patients with coronary heart disease and cardiac failure].
    Mendoza-González C
    Arch Cardiol Mex; 2006; 76 Suppl 2():S209-13. PubMed ID: 17017103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ruptured plaque is associated with larger infarct size following successful percutaneous coronary intervention in ST segment elevation acute myocardial infarction.
    Tanaka A; Shimada K; Namba M; Sano T; Sakamoto T; Akasaka T; Yoshikawa J
    Coron Artery Dis; 2009 Jun; 20(4):260-6. PubMed ID: 19424058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Secondary prevention of the basic risk factors in patients with a history of myocardial infarction].
    Kokutsov A; Petev L
    Vutr Boles; 1990; 29(3):110-6. PubMed ID: 2284791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Acute coronary syndromes and myocardial perfusion. Cardiac magnetic resonance imaging and ultrafast CT].
    Furber A; Genée O; Delépine S; Prunier F; Geslin P
    Arch Mal Coeur Vaiss; 2005 Nov; 98(11):1062-70. PubMed ID: 16379100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Myocardial infarction and oral contraceptives].
    Bounhoure JP; Galinier M; Roncalli J; Assoun B; Puel J
    Bull Acad Natl Med; 2008 Mar; 192(3):569-79; discussion 579. PubMed ID: 18819701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry).
    Lee JH; Park HS; Chae SC; Cho Y; Yang DH; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH;
    Am J Cardiol; 2009 Jul; 104(2):182-9. PubMed ID: 19576343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction.
    Napodano M; Tarantini G; Ramondo A; Cacciavillani L; Corbetti F; Marra MP; Fraccaro C; Peluso D; Razzolini R; Iliceto S
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):44-50. PubMed ID: 19145116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.
    Seyfarth M; Kastrati A; Mann JF; Ndrepepa G; Byrne RA; Schulz S; Mehilli J; Schömig A
    Am J Kidney Dis; 2009 Nov; 54(5):830-9. PubMed ID: 19592145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atherothrombosis: management of patients at risk.
    Mas JL
    Int J Clin Pract; 2005 Apr; 59(4):407-14. PubMed ID: 15853855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sudden cardiac death in patients with silent myocardial ischemia after myocardial infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]).
    Schoenenberger AW; Kobza R; Jamshidi P; Zuber M; Abbate A; Stuck AE; Pfisterer M; Erne P
    Am J Cardiol; 2009 Jul; 104(2):158-63. PubMed ID: 19576339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
    Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
    Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The challenge of risk reduction therapy for cardiovascular disease.
    Smith SC
    Am Fam Physician; 1997 Feb; 55(2):491-500. PubMed ID: 9054219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mortality after first myocardial infarction in Greek patients: a 4-year follow-up study.
    Kolovou GD; Mihas C; Kotanidou A; Dimoula Y; Karkouli G; Kadda O; Anagnostopoulou K; Mikhailidis DP; Marvaki C
    Angiology; 2009; 60(5):582-7. PubMed ID: 19671545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
    Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
    J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Quantitative evaluation of myocardial ischemia using imaging methods].
    Guéret P; Bontemps T; Leymarie JL; Bensaid J
    Arch Mal Coeur Vaiss; 1987 Dec; 80 Spec No():67-71. PubMed ID: 3128235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.